Director Julia A. Haller Gottsch filed a Form 144 notice of proposed sale of 3,800 shares of Bristol Myers Squibb Co common stock, with an approximate sale date of November 5, 2026, through Merrill Lynch.
Key Highlights
- Seller and role: Julia A. Haller Gottsch, listed as a Director of Bristol Myers Squibb Co
- Shares proposed for sale: 3,800 shares of common stock
- Aggregate market value: $250,000, according to the filing
- Approximate sale date: November 5, 2026, via broker Merrill Lynch in Towson, Maryland
- Shares outstanding: 2,044,085,831 shares, as reported in the filing
- Source of securities: Two stock bonus acquisitions from Bristol Myers Squibb - 851 shares acquired June 13, 2021, and 2,949 shares acquired June 3, 2022
- Prior sales in past 3 months: Nothing to report, per the filing
Bristol Myers Squibb Director Files Rule 144 Sale Notice for 3,800 Shares
Bristol Myers Squibb Co (NYSE:BMY) director Julia A. Haller Gottsch filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of 3,800 shares of the company's common stock. The filing identifies Merrill Lynch, located at 901 Dulaney Valley Rd, Suite 516, Towson, Maryland 21204, as the broker for the transaction. The aggregate market value of the shares to be sold is listed as $250,000 in the notice.
According to the filing, the shares proposed for sale were acquired through two separate stock bonus transactions from Bristol Myers Squibb. The first acquisition consisted of 851 shares on June 13, 2021, with payment described as stock options. The second acquisition consisted of 2,949 shares on June 3, 2022, also with payment described as stock options. The filing reports no sales by the director during the three months preceding this notice.
The filing states that the total number of shares of Bristol Myers Squibb common stock outstanding is 2,044,085,831. The Form 144 was submitted as a live filing under SEC File Number 001-01136, and the notice date is recorded as November 5, 2026. The form was signed by Ashley Rowett.
What Was Disclosed
A Form 144 notice was filed on November 5, 2026, disclosing a proposed sale of 3,800 Bristol Myers Squibb common shares by Director Julia A. Haller Gottsch, with an aggregate market value of $250,000, sourced from stock bonus acquisitions in 2021 and 2022.



Please wait processing your request...